N
INO icon

Nuveen’s Inovio Pharmaceuticals INO Stock Holding History

Nuveen’s Portfolio INO Stock Details INO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-103,297
Closed -$168K – 3327
2025
Q1 		$168K Buy
103,297
+56,806
+122% +$114K ﹤0.01% 3152
2024
Q4 		$85.1K Hold
46,491
– – ﹤0.01% 3300
2024
Q3 		$269K Hold
46,491
– – ﹤0.01% 3169
2024
Q2 		$376K Buy
+46,491
New +$489K ﹤0.01% 3088
2023
Q2 		– Sell
-180,997
Closed -$1.78M – 3246
2023
Q1 		$1.78M Buy
180,997
+10,624
+6% +$181K ﹤0.01% 2377
2022
Q4 		$3.19M Buy
170,373
+73,695
+76% +$1.67M ﹤0.01% 2163
2022
Q3 		$2M Buy
96,678
+379
+0.4% +$9.7K ﹤0.01% 2404
2022
Q2 		$2M Buy
96,299
+14,167
+17% +$399K ﹤0.01% 2436
2022
Q1 		$3.58M Buy
82,132
+11,062
+16% +$498K ﹤0.01% 2242
2021
Q4 		$4.25M Sell
71,070
-7,944
-10% -$636K ﹤0.01% 2216
2021
Q3 		$6.79M Sell
79,014
-101,178
-56% -$10.2M ﹤0.01% 2051
2021
Q2 		$20M Buy
180,192
+33,053
+22% +$3.17M 0.01% 1362
2021
Q1 		$16.4M Buy
147,139
+36,749
+33% +$4.83M 0.01% 1464
2020
Q4 		$11.7M Buy
110,390
+29,862
+37% +$3.98M ﹤0.01% 1599
2020
Q3 		$11.2M Sell
80,528
-9,909
-11% -$2.07M ﹤0.01% 1451
2020
Q2 		$29.2M Buy
90,437
+44,131
+95% +$7.09M 0.01% 809
2020
Q1 		$4.13M Buy
46,306
+18,630
+67% +$1.15M ﹤0.01% 1825
2019
Q4 		$1.1M Sell
27,676
-9,077
-25% -$273K ﹤0.01% 2655
2019
Q3 		$904K Sell
36,753
-1,053
-3% -$32K ﹤0.01% 2740
2019
Q2 		$1.33M Buy
+37,806
New +$1.5M ﹤0.01% 2623

Other funds holding INO

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Nuveen's INO Position: Q2 2025 in Review

Nuveen sold out of Inovio Pharmaceuticals (INO) in Q2 2025, closing a stake of 103,297 shares — an estimated $168K sold.

Nuveen first reported a position in INO in Q2 2019 and held it in 20 quarters. The position peaked at $29.2M in Q2 2020. 103 funds tracked by Wall St. Rank hold INO as of Q2 2025.

  • Nuveen reported no remaining Inovio Pharmaceuticals position as of Q2 2025 after selling out during the quarter.
  • Nuveen sold 103,297 Inovio Pharmaceuticals shares in Q2 2025, an estimated $168K.
  • Nuveen first reported a position in Inovio Pharmaceuticals in Q2 2019 and held it in 20 quarters.
  • Nuveen's Inovio Pharmaceuticals position peaked at $29.2M in Q2 2020.
  • 103 funds tracked by Wall St. Rank held Inovio Pharmaceuticals as of Q2 2025.

Based on Nuveen's 13F filing for Q2 2025, filed 12 Aug 2025.